A Review on Artemisia princeps: Pharmacology and Anti-Inflammatory Potential of Phytoconstituents

Author:

Thakur Madhurima1,Kumar Inder2,Dhiman Sunny3

Affiliation:

1. School of Pharmacy, Abhilashi University, Mandi, HP, India.

2. Minerva College of Pharmacy, Indora, Distt. Kangra, HP, India.

3. Chandigarh College of Pharmacy, CGC Landran, Mohali, Punjab, India.

Abstract

Higher organisms developed the inflammation as a defence mechanism against infection and injuries. Chronic Inflammation is a progressive reaction which end at damage of living tissues. Several synthetic compounds had been used for fighting against uncontrolled inflammation. However, some of these compounds had significant adverse along with their anti-inflammatory properties. So, there is still need of some new anti-inflammatory compounds with least or no adverse effects. Numerous herbs including Ashwagandha, Calendula, Cat’s claw; Chamomile, Cilantro, Licorice root, Parsley, Curcuma longa, Zingiber officinale, Rosmarinus officinale, Borago officinale, Rosemary, Evening primrose, Devil’s claw had been evaluated for their anti-inflammation potentials and potent results was obtained with non-significant adverse effects. Plant named as Artemisia princeps. Family-Asteraceae has been evaluated for its pharmacological abilities and proved as significant herb for treatment of various pathological conditions. This review comprises the pharmacological abilities of Artemisia princeps. Linn and its Phytoconstituents with special emphasis on its anti-inflammatory potential. In the current literature survey, Selected plant was found to contain substantial number of phytoconstituent with pharmacological abilities Including Apigenin, Diosmetin, Eriodicytol, Eupafolin, Kaempferol, Vitex, Jaceosidine and Querecetine. Further literature survey also provides the anti-inflammatory potentials of phytoconstituents present in Artemisia princeps.

Publisher

A and V Publications

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3